Fielmann (FIE) AI Stock Analysis

• Market Cap: €3.54B
• Dividend Yield: 2.69%
• Average Volume (3M): 63.96K
• Price to Earnings (P/E): 19.0
• Beta (1Y): 0.77
• Revenue Growth: 7.56%
• EPS Growth: 33.98%
• Country: DE
• Employees: 20,221
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 1.56
• Shares Outstanding: 84,000,000
• 10 Day Avg. Volume: 37,023
• 30 Day Avg. Volume: 63,960
• PEG Ratio: 0.52
• Price to Book (P/B): 3.72
• Price to Sales (P/S): 1.50
• P/FCF Ratio: 10.39
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €63.00
• Price Target Upside: 32.21% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4
• EPS Forecast (FY): 2.65
• Revenue Forecast (FY): €2.57B

• Rating: 64 Neutral
• Price Target: €45.00 ▼(-5.56% Downside)
• Action: Reiterated Date: 05/03/26
• Date: Action: Reiterated 05/03/26

Positive Factors

Omnichannel retail footprint

Fielmann’s combined physical store network and e-commerce model creates enduring distribution breadth and customer touchpoints. This omnichannel presence supports repeat purchases (frames, lenses, contact lenses), improves cross-sell and retention, and cushions revenue against localized disruptions over 2–6 months.

Negative Factors

Rising leverage

Higher leverage versus earlier years reduces financial flexibility and increases vulnerability to revenue shocks or higher interest rates. With debt roughly nearing parity with equity, sustained operating weakness or margin pressure could strain cash flow and limit strategic options over the next several quarters.

Fielmann Business Overview & Revenue Model

Company Description

Fielmann Aktiengesellschaft, together with its subsidiaries, engages in the investment in and operation of optical and hearing aid businesses. The company manufactures and sells visual aids and other optical products, including glasses, frames, le...

Read more

Fielmann Aktiengesellschaft, together with its subsidiaries, engages in the investment in and operation of optical and hearing aid businesses. The company manufactures and sells visual aids and other optical products, including glasses, frames, le...

How the Company Makes Money

Fielmann primarily makes money by selling eyewear products and associated services through its omnichannel retail model (physical stores and e-commerce). Key revenue streams include: (1) Prescription eyeglasses: sales of frames and ophthalmic lens...

Read more

Fielmann primarily makes money by selling eyewear products and associated services through its omnichannel retail model (physical stores and e-commerce). Key revenue streams include: (1) Prescription eyeglasses: sales of frames and ophthalmic lens...

Fielmann Financial Statement Overview

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.79B	2.44B	2.26B	1.97B	1.76B	1.68B
Gross Profit	1.44B	656.10M	1.81B	1.57B	1.38B	1.34B
EBITDA	341.88M	553.35M	475.73M	399.17M	346.99M	389.78M
Net Income	130.32M	203.73M	152.11M	127.64M	103.66M	136.85M
Balance Sheet
Total Assets	2.39B	2.66B	2.37B	1.99B	1.77B	1.74B
Cash, Cash Equivalents and Short-Term Investments	287.03M	226.87M	101.68M	81.83M	149.87M	235.54M
Total Debt	548.74M	884.03M	873.85M	592.15M	505.66M	458.26M
Total Liabilities	1.42B	1.67B	1.46B	1.06B	909.10M	863.09M
Stockholders Equity	957.51M	981.78M	899.13M	867.65M	804.22M	819.83M
Cash Flow
Free Cash Flow	0.00	352.02M	327.41M	196.00M	182.69M	260.15M
Operating Cash Flow	0.00	464.74M	410.09M	282.79M	268.08M	346.69M
Investing Cash Flow	0.00	-116.53M	-331.17M	-143.25M	-159.85M	-74.85M
Financing Cash Flow	0.00	-223.63M	-44.27M	-132.00M	-209.22M	-201.22M

Fielmann Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 47.65
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:FIE, the sentiment is Positive. The current price of 47.65 is above the 20-day moving average (MA) of 44.36, above the 50-day MA of 43.94, and below the 200-day MA of 47.72, indicating a neutral trend. The MACD of 0.88 indicates Negative momentum. The RSI at 71.19 is Negative, neither overbought nor oversold. The STOCH value of 95.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:FIE.

Fielmann Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JEN	71 Outperform	€2.05B	10.57	7.38%	1.97%	-6.26%	-22.28%
BOSS	67 Neutral	€2.55B	37.48	17.17%	3.86%	-2.71%	9.98%
AFX	65 Neutral	€2.30B	17.81	6.77%	1.50%	7.82%	-19.80%
FIE	64 Neutral	€3.54B	18.97	19.74%	2.69%	7.56%	33.98%
ZAL	57 Neutral	€5.16B	-15.14	7.72%	―	20.20%	-56.58%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%